Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group LSE:RENE London Ordinary Share GB00B0DZML60 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 1.95p 1.90p 2.00p 1.95p 1.95p 1.95p 1,706,384 07:45:41
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -18.2 -0.5 - 61.61

Reneuron Share Discussion Threads

Showing 5451 to 5473 of 5475 messages
Chat Pages: 219  218  217  216  215  214  213  212  211  210  209  208  Older
DateSubjectAuthorDiscuss
08/8/2017
14:46
Long way to go yet for me to get my money back...
stewart_25
08/8/2017
09:37
The strength here continues. It doesn't matter that products and profit might be some way off (pace Amazon, Facebook, etc etc etc) with this kind of co the valuation is all about the potential and, as Woodford notes, there is a great deal in this technology.
small crow
07/8/2017
15:55
Anyone going to the AGM next Month? 06/09/17 London. Freddie? Anyone?
algernon2
07/8/2017
09:55
I agree with Woodford on the potential for Reneuron but the rationale makes no sense. These guys are burning cash at ~£13m per year and their therapeutic candidates are nowhere near the clinic. So the market is discounting this. The fact that they have £54m cash just means they've got ~ 4 years, at this rate of cash burn, to progress the technology. That said, if this thing was listed in the US, I expect it would be worth 10 x the current market cap, given how exciting and world-leading the technology is and how US investors tend to have more risk appetite for innovation. One for the very long-term. 2p very attractive levels!
rrb
07/8/2017
09:45
Ze Germans always state the bleeding obvious! Now they're trying to steal our shares.
alphapig
07/8/2017
09:22
"mkt cap equals cash on balance sheet" - That's as at today. Henceforth for the immediate future money is going out and none coming in! - So as always you pays your money and takes your chance!
deutsch3
07/8/2017
08:29
Good write up by Woodford mkt cap equals cash on balance sheet
nw99
07/8/2017
08:22
Someone likes
richtea2517
07/8/2017
07:37
Time to buy?
rayrac
06/8/2017
13:17
I seem to remember the cash was raised in a big share issue and is needed to progress the drugs through development and trials, so its a diminishing cash pile rather than something built up from commercial revenues. No position here at present.
deccer1
06/8/2017
11:19
Spot on nw
fredd1eboy
06/8/2017
08:53
Interesting cash on Bal sheet = mkt cap could be a big winner
nw99
04/8/2017
16:21
Massive volume spike
bean02
04/8/2017
15:29
About time ...
small crow
04/8/2017
14:39
Extract from today's report. My sentiments exactly. https://www.investegate.co.uk/wood-pat-captst-plc/rns/half-year-report/201708040700040863N/ By way of example, ReNeuron, a leading clinical stage stem cell business, had a market capitalisation at period end of £54m. At its latest financial year end (31 March 2017), the company held £53m in cash on its balance sheet, meaning that the stock market is effectively ascribing a value of £1m to the future value of this company's world-class technology. This appears ludicrous, in my view, but it also serves as an effective demonstration of how market inefficiencies can lead to compelling long-term investment opportunities.
127tolmers
02/8/2017
12:05
I really feel for you guys as a past holder who saw enough to be disillusioned and sold out. Please do not say that rocket fuel or myself for that matter did not raise a red flag over the moral fibre of the controlling people behind this company; The price is discounting the cash by liabilities when a premium is deserved if they have not lied to you
norbus
02/8/2017
10:00
Its a disgrace. Poor Reneuron management has allowed the share price to drop to this ridiculous level. Olav Hellebo with is over inflated salary should be sacked, unless he leads a recovery. At this sp, when we do go for a cash call, we will be ravaged. Get your act together Olav and earn your salary.
fredd1eboy
02/8/2017
09:25
Over 3 billion shares in issue and it drops on that?
alphapig
31/7/2017
11:11
Interesting yes, but old. Does not contain early Ph2 results which improve conclusions. See recent Proactiv presentations.
127tolmers
29/7/2017
16:50
Interesting article https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510676/
fredd1eboy
29/7/2017
16:49
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551067e6/
fredd1eboy
27/7/2017
08:14
Related news: https://www.theguardian.com/science/2017/jul/26/stem-cell-brain-implants-could-slow-ageing-and-extend-life-study-shows
small crow
26/7/2017
14:03
No placing; Shake up the register and wake up the dead.
norbus
Chat Pages: 219  218  217  216  215  214  213  212  211  210  209  208  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20170818 14:32:17